Role of hepatic arterial embolisation in the treatment for metastatic insulinoma. Report of two cases and review of the literature

Acta Clinica Belgica

Volumn 52, Issue 5, 1997, Pages 263-274

  Berwaerts, J ^a   Verhelst, J ^a   Hubens, H ^a   Kunnen, J ^a   Schrijvers, D ^b   Joosens, E ^a   Mahler, Ch ^a   Van Gaal, L ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

'CONTOUR'; C PEPTIDE; CORTICOSTEROID; DIAZOXIDE; FLUOROURACIL; GELFOAM; GLUCAGON; GLUCOSE; HISTAMINE H1 RECEPTOR ANTAGONIST; INSULIN; METHYLPREDNISOLONE; OCTREOTIDE; POLYVINYL ALCOHOL SPONGE; PROINSULIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIET; FEMALE; GLUCOSE BLOOD LEVEL; HEPATIC ARTERY; HUMAN; INSULINOMA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; PALLIATIVE THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME; ULTRASOUND;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; INSULINOMA; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0030691053     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bieligk S, Jaffe BM. Islet cell tumors of the pancreas. Surg Clin North Am. 1995; 75: 1025-40.
2. Service FJ, Food-deprived hypoglycemias. In: DeGroot LJ, ed. Endocrinology, 3rd ed. Philadelphia: WB Saunders Company, 1995: 1612-8.
3. Fraher DL, Jensen RT. Insulinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology. Philadelphia: Lippincott-Raven Publishers 1997: 1689-92.
4. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma: incidence, recurrence and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991; 66: 711-9.
5. Danforth DN, Gordon P, Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery. 1984; 96: 1027-36.
6. Wirsching R, Spelsberg F, Landgraf R. Inselzellcarcinom mit organischem Hyperinsulinismus: Klinik, Diagnostik und Therapie. Klin Wochenschr. 1982; 60: 815-22.
7. Hesdorffer CS, Stoopler M, Javitch J. Aggressive insulinoma with bone metastases. Am J Clin Oncol. 1989; 12: 498-501.
8. Legaspi A, Brennan MF. Management of islet cell carcinoma. Surgery. 1988; 104: 1018-23.
9. Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am. 1989; 18: 45-74.
10. Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. 1988; 104: 1011-7.
11. Kim DG, Chejfec G, Prinz RA. Islet cell carcinoma of the pancreas. Am Surg. 1989; 55: 325-32.
12. Shaklai M7 Aderka D, Blum I et al. Suppression of hypoglycemia attacks and insulin release by propranolol in a patient with metastatic insulinoma. Diabete Metab. 1977; 3: 155-8.
13. Hofeldt FD, Dippe SE, Levin SR et al. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma. Diabetes. 1973; 23: 192.
14. Federspil G, Casara D, Stauffacher W. Chlorpromazine in the treatment of endogenous organic hyperinsulinism. Diabetologia. 1974; 10: 198.
15. Ulbrecht JS, Schmeltz R, Aarons JH et al. Insulinoma in a 94-year-old woman: long-term therapy with verapamil. Diabetes Care. 1986; 9: 186-8.
16. Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine: in vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984; 77: 41-46.
17. Curnow RT, Carey RM, Taylor A, Johanson A, Murad F. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. N Engl J Med. 1975; 292: 1385-6.
18. Osei K, O'Dorisio TM. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth and gastro-enteropancreatic hormones. Ann Intern Med. 1985; 103: 223-5.
19. Kvols LK, Buck M, Moertel CG et al. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med. 1987; 107: 162-8.
20. Oberg K. Chemotherapy and biotherapy in neuroendocrine tumors. Curr Opin Oncol. 1993; 5: 110-20.
21. Broder LE, Carter SK. Pancreatic islet cell carcinoma: II results of therapy with streptozotocin in 52 patients. Ann Intern Med. 1973; 79: 108-18.
22. Schein P, Kahn Rt Gorden P et al. Streptozotocin for malignant insulinomas and carcinoid tumor: report of eight cases and review ofthe literature. Arch Intern Med. 1973; 132: 555-61.
23. Gefel A, Flatau E, Ayalon D, Papo J, Loewenthal M. Malignant metastatic insulinoma treated with streptozotocin: report of a case and review of the literature. Clin Endocrinol. 1975; 4: 461-8.
24. Herbai G, Lundin A. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin: review of 21 cases described in detail in the literature and report of complete remission of a new case. Acta Med Scand. 1976; 200: 447-52.
25. Sadoff L. Control of hypoglycemia with L-asparaginase in a patient with islet cell cancer. J Clin Endocrinol Metab. 1973; 36: 334-7.
26. Kiang DT, Frenning DH, Bauer GE. Mithramycin for hypoglycemia in malignant insulinoma. N Engl J Med. 1978; 299: 134-5.
27. Ajani JA, Levin B, Wallace S. Systemic and regional therapy of advanced islet cell tumors. Gastroenterol Clin North Am. 1989; 18: 923-30.
28. Olberg K. The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am. 1993; 22: 941-52.
29. Moertel CG, Hanley JA, Johnson LA. Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N Engl J Med. 1980; 303: 1189-94.
30. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozotocin-doxorubicin, streptozotocin-fluorouracil or chlorozotocin in the treatment of advanced islet cell carcinoma. N Engl J Med. 1992; 326: 519-23.
31. Hall JT, Wallace S, Carrasco CH et al. Gastrointestinal and pancreatic endocrine tumours. Baillieres Clin Endocrinol Metab. 1989; 3: 121-52.
32. Carrasco CH, Chuang VP, Wallace S. Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology. 1983; 149: 79-83.
33. Ajani JA, Carrasco CH, Charnsangavej C et al. Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization. Ann Intern Med. 1988; 108: 340-4.
34. Winkelbauer FW, Niederle B, Graf O et al. Malignant insulinoma: permanent hepatic artery embolization of liver metastases: preliminary results. Cardiovasc Intervent Radiol. 1995; 18: 353-9.
35. Marlink RG, Lokich JJ, Robins JR, Clouse ME. Hepatic arterial embolization for metastatic hormone-secreting tumors: technique, effectiveness and complications. Cancer. 1990; 65: 2227-32.
36. Moertel CG, Johnson CM, McKusick MA et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994; 120: 302-9.
37. Stockmann F, Von Romatowski HJ, Reimold WV, Schuster R, Creutzfeldt W. Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases. Z Gastroenterol. 1984; 22: 652-60.
38. Lee SM, Forbes A, Williams R. Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: successful treatment by hepatic artery embolization and chemotherapy. Eur J Surg Oncol. 1988; 14: 265-8.
39. Wells JL, Heath DA, West JR. Hepatic artery embolization in the treatment of intractable hypoglycemia. J R Soc Med. 1990; 83: 592-3.
40. Clouse ME, Perry LJ, Stuart K, Stokes KR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion. 1994; 55 (suppl 3): 92-7.
41. Mavligit GM, Pollock RE, Evans HL, Wallace S. Durable hepatic tumor regression after chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer. 1993; 72: 375-80.
42. Ruszniewski P, Rougier P, Roche A et al. Hepatic arterial chemoembolization in patients with liver metastasis of endocrine tumors. A prospective phase II study in 24 patients. Cancer. 1993; 71: 2624-30.
43. Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery. 1994; 116: 1111-7.
44. Nesovic M, Ciric J, Radojkovic S, Zarkovic M, Durovic M. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization. J Endocrinol Invest. 1992; 15: 543-7.
45. Mounedji-boudiaf L, Rougier P, Culine S, et al. Traitement des insulinomes malins métastatiques: deux observations. Presse Méd. 1995; 24: 894-6.